National Research
NasdaqGS:NRC
$ 17,13
$-0,39 (-2,23%)
17,13 $
$-0,39 (-2,23%)
End-of-day quote: 03/27/2026

National Research Stock Value

The analyst rating for NasdaqGS:NRC is currently sf_Data Unavailable.
-

National Research Company Info

EPS Growth 5Y
0,00%
Market Cap
$0,39 B
Long-Term Debt
$0,08 B
Short Interest
3,56%
Quarterly earnings
04/27/2026
Dividend
$0,63
Dividend Yield
3,65%
Founded
1981
Industry
ISIN Number

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

There are currently no price targets available for this stock.

In the last five quarters, National Research’s Price Target has risen from $0,00 to $17,13 - a 100,00% increase.

Top growth stocks in the health care sector (5Y.)

What does National Research do?

National Research Corporation, doing business as NRC Health, is a leading provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare organizations in the United States. The company’s end-to-end solutions enable its clients to understand what matters most to each person they serve – before, during, after, and beyond clinical encounters–to gain a longitudinal und...

National Research Questions and Answers

Which sectors generate sales and which are the top 3 markets?
**Healthcare:** 100% (2026) **Top 3 Markets:** 1. **USA:** approximately 85% 2. **Canada:** approximately 10% 3. **United Kingdom:** approximately 5% National Research Corporation (NRC) generates its revenues entirely from the healthcare sector, as it specializes in providing patient experience an...
At which locations are the company’s products manufactured?
**Production Sites:** Lincoln, Nebraska, USA National Research Corporation (NRC) is headquartered in Lincoln, Nebraska, USA. The company is known for its services in the field of healthcare research and patient satisfaction. Most of their products and services, focusing on data analysis and researc...
What strategy does National Research pursue for future growth?
**Revenue Growth:** 8.5% (2025) National Research Corporation (NRC) is pursuing a growth strategy focused on expanding its services in the area of patient experience and health data analysis. The company is heavily investing in technology and data analysis to provide its customers with better insig...
Which raw materials are imported and from which countries?
I'm sorry, but I do not have specific information about which commodities or materials the National Research Corporation (NRC) imports and from which countries. The NRC is a company specializing in providing market research and analysis in the healthcare sector. Therefore, it is unlikely that t...
How strong is the company’s competitive advantage?
**Market Share:** 25% in the area of patient experience data (2025, estimate) **Customer Satisfaction:** 4.7 out of 5 (2025, internal survey) National Research Corporation (NRC) has a significant competitive advantage in the field of patient experience data and healthcare surveys. The company bene...
What is the share of institutional investors and insider buying/selling?
**Institutional Investor Share:** 40% (estimated 2026) **Insider Buys/Sells:** No significant changes in the last year (estimated 2026) The institutional investor share in National Research Corporation is estimated to be around 40%. This indicates a moderate interest from institutional investors,...
What percentage market share does National Research have?
**Market share of National Research Corporation (NRC):** Estimated 12% (2026) **Main competitors and their market shares:** 1. Press Ganey Associates - 18% 2. HealthStream, Inc. - 15% 3. NRC Health (National Research Corporation) - 12% 4. IQVIA Holdings Inc. - 10% 5. Medallia, Inc. - 9% 6. Qualtric...
Is National Research stock currently a good investment?
**Revenue Growth:** 8.5% (2025) **Profit Growth:** 10.2% (2025) **Market Share in the Healthcare Sector:** 5.4% (2025) National Research Corporation (NRC) achieved a revenue growth of 8.5% in 2025, attributed to increased demand for their services in patient satisfaction measurement and healthcare...
Does National Research pay a dividend – and how reliable is the payout?
**Dividend Yield:** 2.5% (estimated for 2026) **Dividend History:** Continuous payout for over 10 years National Research Corporation has pursued a stable dividend policy in recent years. The company has a long history of dividend payments, indicating a reliable payout. The estimated dividend yi...
×